Teladoc Inc Stock News

Teladoc Health's (TDOC) Q1 results suffer from weak contributions from the BetterHelp unit. Management expects U.S. Integrated Care Members of 92-94 million for 2024, up from the prior mentioned 90-92

Teladoc's latest quarterly performance didn't meet expectations. It posted a loss of almost $82 million for the period.

Teladoc Health, Inc. (NYSE:TDOC ) Q1 2024 Earnings Call Transcript April 25, 2024 5:00 PM ET Company Participants Adam Vandervoort - Chief Legal Officer Mala Murthy - Acting Chief Executive Officer an

Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street

Teladoc (TDOC) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.37 per share a year ago.

Teladoc's (TDOC) first-quarter results are expected to have benefited from higher visits. However, high costs might have partially offset the positives.

Teladoc's business peaked during the early days of the pandemic but has been struggling since. The company does have several things going its way, including a long runway in its industry.

In the latest trading session, Teladoc (TDOC) closed at $13.14, marking a +0.08% move from the previous day.

At one point Cathie Wood was the hottest money manager on Wall Street. Her family of Ark Invest exchange-traded funds (ETF) grew at a blistering pace, at one point doubling the returns for investors.

Ark Invest bought shares of Roku, Teladoc, and Blade Air Mobility on Monday. Roku has lost more than a third of its value this year.

Teladoc shares are down significantly from their all-time highs. The stock's price-to-sales ratio is attractive.

PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2024 results on Thursda

Ark Invest bought shares of Palantir, Teladoc, and Roku on Thursday. Palantir has more than tripled from where it was at the start of last year, but momentum has been slipping in recent weeks.

Teladoc Health's board of directors announced the departure of its CEO. Shares of Teladoc have lost nearly half their value since the company's initial public offering in 2015.

Teladoc CEO Jason Gorevic is leaving the company. The company's CFO will take over in the short term, while the board seeks a new long-term CEO.